Low levels of HDL and high levels of LDL cholesterol are both important predictors of cardiovascular disease. LDL cholesterol levels are effectively lowered by statin therapy, significantly ...

Inhibition of cholesteryl ester transfer protein (CETP) increases HDL-cholesterol levels and decreases LDL-cholesterol levels; therefore, CETP inhibition represents a potential therapeutic approach.

depletion of cholesteryl esters, covalent modification of HDL apolipoproteins and attenuated antiatherogenic function of apolipoprotein AI. Low circulating levels of HDL cholesterol might ...

My cholesterol has been on the rise for the past few years – and not just a slow creep. For most of my life, my LDL (often referred to as ‘bad’ cholesterol) was solidly under 120 mg/dl.

HDL-C: HDL cholesterol; LDL-C: LDL cholesterol ... Anacetrapib is an inhibitor of cholesteryl ester transfer protein that is in development to address residual cardiovascular risk by raising ...

Cholesterol is basically waxy substance that builds up in the arteries creating a blockage for optimal blood and oxygen flow. Increased levels of Low-density lipoprotein (LDL) can put th heart ...

(Princeton, NJ) expresses both cholesteryl ester transfer protein and apolipoprotein B100, resulting in human-like high-density lipoprotein (HDL) and low-density lipoprotein (LDL) cholesterol levels.

High levels of low-density lipoprotein (LDL), often referred to as “bad cholesterol,” can lead to serious health issues, including heart disease and stroke. While many people are aware of the ...